Dental Bone Graft Substitute Market

The global dental bone graft substitute market is projected to reach 1.8 billion in 2029 from USD 1.3 billion in 2024, at a CAGR of 7.7% between 2024 and 2029.

The key factors which are driving the growth of the dental bone graft substitute market includes, the increasing popularity of dental implants as a tooth replacement option creates a direct need for bone graft substitutes also dental bone graft substitutes play a crucial role in jawbone regeneration and reconstruction which are some of the factors driving the growth of the market.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the dental bone graft substitute market include include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland),  Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and  Arora Biosurgery Ltd. (New Zealand).

Medtronic Plc. (Ireland)

Medtronic develops and manufactures healthcare technologies and therapies for a variety of medical conditions. Their product portfolio includes cardiac and vascular devices such as pacemakers, defibrillators, heart valves, stents, vascular access devices, minimally invasive therapies devices which includes surgical staplers, robotic surgical systems, ablation catheters, neuromodulation devices which includes deep brain stimulation systems, spinal cord stimulation systems, diabetes devices which includes insulin pumps, continuous glucose monitoring systems, medical surgical devices which includes spinal implants, surgical navigation systems.

Kuraray Co. Ltd (Japan)

Kuraray is a leading innovator in specialty chemicals, synthetic fibers, and other materials. They have a long history of developing cutting-edge technologies, with their first success being the commercialization of synthetic rayon in 1926. Kuraray's product portfolio encompasses a wide range of materials used in various industries, including automotive, healthcare, electronics, and environmental solutions. Kuraray is committed to sustainability and incorporates it into their corporate philosophy. They focus on developing eco-friendly products and processes to minimize their environmental impact.

HENRY SCHEIN, INC. (US)

Henry Schein is an American company and a Fortune World's Most Admired Company. It is the largest distributor of healthcare products and services in the world, with a presence in 32 countries. The company supplies a wide range of medical, dental, and animal health products to office-based healthcare professionals. They also offer practice management software, equipment financing, and other value-added services.

Related Reports:

Dental Bone Graft Substitutes Market by Type ( Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (sinus Lift, Ridge Augumentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region- Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]